H.R. 10050 directs the Secretary of Health and Human Services to conduct a study of how pharmacy benefit managers audit pharmacies that dispense drugs covered by Medicare, Medicaid, and private insurance plans. The study must be completed and reported to Congress within one year of the bill's enactment and should examine the financial impact of these audits on independent and retail pharmacies, evaluate whether documentation timeframes are reasonable given how long medications remain usable, and assess the transparency of current audit practices. The bill specifically asks the study to include recommendations for making audits less burdensome on pharmacists while maintaining their integrity, drawing input from independent pharmacists, pharmacy benefit managers, healthcare providers, and relevant government agencies. This legislation affects independent pharmacies, pharmacy benefit managers, and healthcare providers involved in administering federal and private insurance drug benefits. The bill does not authorize any specific funding amount but requires the health department to complete the study using existing resources within the one-year timeline.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.